Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state
about
Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor HeteromerizationStructural Studies of G Protein-Coupled ReceptorsOX1 and OX2 orexin/hypocretin receptor pharmacogeneticsLarge-scale production and protein engineering of G protein-coupled receptors for structural studiesComputational approaches for modeling GPCR dimerizationQuaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs.Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-associationVisualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2A G Protein-Coupled Receptor Dimerization Interface in Human Cone OpsinsStructure-guided development of heterodimer-selective GPCR ligandsInvited review: GPCR structural characterization: Using fragments as building blocks to determine a complete structure.Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation.Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at WorkTransmembrane domains of attraction on the TSH receptor.Membrane driven spatial organization of GPCRs.Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex.Mutual Regulation of NOD2 and RIG-I in Zebrafish Provides Insights into the Coordination between Innate Antibacterial and Antiviral Signaling Pathways.Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptorProgrammable nanoscaffolds that control ligand display to a G-protein-coupled receptor in membranes to allow dissection of multivalent effects.A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophreniaMethods used to study the oligomeric structure of G-protein-coupled receptors.Pivotal role of extended linker 2 in the activation of Gα by G protein-coupled receptor.An analysis of oligomerization interfaces in transmembrane proteins.Single molecule analysis of functionally asymmetric G protein-coupled receptor (GPCR) oligomers reveals diverse spatial and structural assemblies.Structural features of β2 adrenergic receptor: crystal structures and beyond.Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptorsHeteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.Structural characterization of triple transmembrane domain containing fragments of a yeast G protein-coupled receptor in an organic : aqueous environment by solution-state NMR spectroscopyAllosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsDistinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers.Dynamic Cholesterol-Conditioned Dimerization of the G Protein Coupled Chemokine Receptor Type 4.Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model.A conformational study of protonated noradrenaline by UV-UV and IR dip double resonance laser spectroscopy combined with an electrospray and a cold ion trap method.Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction InterfaceCholesterol-dependent Conformational Plasticity in GPCR Dimers.Cofactoring and dimerization of proteinase-activated receptorsProtease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
P2860
Q26749791-B406902E-6BD0-4A49-803E-ABD22063FC76Q26783016-75F9FE30-D25F-4F2D-935A-E97300D159E5Q26865384-00907A52-D208-42FF-BAF7-E4048C350F99Q26866010-6BC98B9B-B7F9-4C8B-975B-EE64D63AD6BAQ27001137-FC8A5E4D-1FD9-478C-B097-E87E0D82F6BAQ27305013-98C555FB-91F5-4682-8976-566201320597Q27319797-65019010-4861-408D-86A6-4131CAA9CE54Q27348715-886CDC48-7871-4379-B334-9A4C1F663843Q28249697-BBE1D41C-DA71-493F-8113-AA4C3BD0AACFQ28817975-69E78F6C-F466-4D82-800F-073A45B6B762Q28828634-DF39D562-1661-4BB1-A79C-CB354AD43A3BQ30360845-E8F8BE26-DF29-4442-8576-2090D074273EQ30397614-226C783E-FDA1-4F76-A73F-3F575B392974Q30401802-C487D93B-315D-47DC-A3A4-6DF3175E831AQ30408234-77A52D7F-C5AA-4643-BBF0-1D2B32431997Q30549886-B1CF5C2C-FC14-464B-9CFB-903EA0010746Q33613196-1DBA7F84-CF84-4B81-92D9-D7BE86A982BDQ33838519-4487E2C7-E86C-442A-A981-F7E08FA46F95Q34042126-EE38B3E3-2D9B-493E-A8EA-698E27F58FA9Q34145241-736D7382-BB18-482A-9B20-41B29B32834CQ34356107-D5E9D161-09AD-4824-AE03-EA18F5450A31Q34508675-7539A76A-35F7-47DF-A7B0-4E4E7D625A11Q34548734-D96F9DB0-088E-4F2D-9C55-30F06DF9C2FFQ34801401-682B49EE-1186-42F4-8690-9836A43DDBD7Q35019647-F92E63CB-A4EE-4D4E-B5C5-D0D2307FED12Q35080181-1A28254B-CFC1-4DC3-A50C-EFFD613A6FA9Q35093808-3C453FE1-6E9B-4397-8635-90571823486DQ35126350-0C999788-F2D4-4EE7-910D-6816C7F90962Q35279688-6D288703-84AD-426F-9FA3-7C0117EDB7FEQ35554000-75A84470-5F63-4A6D-BBC9-D0FB5A96CA07Q35860717-F637CBB0-FCA5-4A8E-9ED3-3D2E35BA5785Q35860873-3F33EA90-932D-4816-976F-C19757BFD580Q36182026-965FC2F4-8E43-4779-84D1-CD970CD4A79EQ36218464-18C9BC30-C2C6-43BB-9FA9-555BF1C2A95AQ36222134-456949D3-E309-4129-A661-FC0C62345D86Q36264661-96ADA1B5-6001-4C37-945E-C112E610FD2DQ36283412-7DB159DD-CDEC-4D71-90CD-68F85F3910B9Q37184788-C5E5483B-364A-42EA-9413-EC635EBDD87CQ37236116-4F4DA475-E87C-41E7-80CF-84B9EEF6C966Q37289265-D5137225-4637-42D5-AD96-615C019B50A3
P2860
Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Crystal structure of oligomeri ...... ors in ligand-free basal state
@ast
Crystal structure of oligomeri ...... ors in ligand-free basal state
@en
Crystal structure of oligomeri ...... ors in ligand-free basal state
@nl
type
label
Crystal structure of oligomeri ...... ors in ligand-free basal state
@ast
Crystal structure of oligomeri ...... ors in ligand-free basal state
@en
Crystal structure of oligomeri ...... ors in ligand-free basal state
@nl
prefLabel
Crystal structure of oligomeri ...... ors in ligand-free basal state
@ast
Crystal structure of oligomeri ...... ors in ligand-free basal state
@en
Crystal structure of oligomeri ...... ors in ligand-free basal state
@nl
P2093
P2860
P921
P3181
P356
P1476
Crystal structure of oligomeri ...... ors in ligand-free basal state
@en
P2093
J Jillian Zhang
Jianyun Huang
Shuai Chen
Xin-Yun Huang
P2860
P2888
P304
P3181
P356
10.1038/NSMB.2504
P577
2013-04-01T00:00:00Z
P5875
P6179
1036192674